As demand surges, Hardy Diagnostics has exponentially increased manufacturing production in order to supply customers with critical laboratory products during the COVID-19 pandemic
Strategic partnership with Autobio Diagnostics Co., Ltd enables Hardy Diagnostics to become exclusive US supplier of a new rapid, one-step lateral flow assay that detects IgM and IgG antibodies to the SARS-CoV-2 virus
Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA
Comprehensive turnkey system based on industry-leading LabVantage LIMS platform allows laboratories to implement COVID-19 biobanking, testing, and research almost immediately
Under the agreement, Leinco Technologies will co-develop a rapid, point of care, immunodiagnostic test for the detection of the SARS-CoV-2 virus responsible for COVID-19